Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreGet the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific.
Learn MoreExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
Discover Insights"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.
Read The Latest Issue"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers
Learn MoreImproving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search JobsWith increasing population growth, expanding health services and the rising prevalence of lifestyle-associated diseases, the medical nutrition market is anticipated to grow exponentially to ¼ of the global market size.
While the Asia Pacific (APAC) market is attractive, medical nutrition companies face critical pain points regarding formalized frameworks, stakeholder understanding, credibility and pricing.
With Nutrition Health Economics and Outcomes Research (nHEOR), illustrate the value of medical nutrition by complementing traditional clinical development information with real-world evidence. This helps to fill the vacuum of understanding in the unmet population nutrition needs, clarify product values and align health system priorities.
Download this fact sheet to find out more about the critical role of HEOR evidence development in medical nutrition and how it can help advance market access.
For more information, contact us.